Table 5 Mean (SD) and median (IQR) willingness-to-pay values, by cancer and risk level
From: Using willingness-to-pay to establish patient preferences for cancer testing in primary care
n | Mean (SD) £ | Median (IQR) £ | |
|---|---|---|---|
Colorectal | |||
1 % | 354 | 380 (348) | 300 (100 to 700) |
2 % | 351 | 393 (351) | 300 (100 to 700) |
5 % | 373 | 367 (351) | 270 (100 to 700) |
10 % | 385 | 367 (343) | 270 (100 to 700) |
1463 | 377 (348) | 300 (100 to 700) | |
p-value | 0.71 | ||
Lung | |||
1 % | 401 | 305 (326) | 100 (100 to 300) |
2 % | 403 | 339 (336) | 270 (100 to 503) |
5 % | 399 | 360 (349) | 270 (100 to 700) |
10 % | 412 | 365 (346) | 270 (100 to 700) |
1615 | 342 (340) | 224 (100 to 670) | |
p-value | 0.049 | ||
Pancreas | |||
1 % | 389 | 371 (355) | 224 (100 to 700) |
2 % | 405 | 367 (336) | 300 (100 to 700) |
5 % | 378 | 375 (352) | 270 (100 to 700) |
10 % | 401 | 385 (358) | 300 (100 to 700) |
1573 | 374 (350) | 270 (100 to 700) | |
p-value | 0.91 | ||
all cancers (first response only) | |||
1 % | 567 | 312 (327) | 100 (100 to 300) |
2 % | 534 | 366 (347) | 270 (100 to 700) |
5 % | 529 | 360 (347) | 270 (100 to 700) |
10 % | 573 | 377 (351) | 270 (100 to 700) |
2203 | 353 (344) | 224 (100 to 700) | |
p-value | 0.0075 | ||